Precigen, Inc. financial data

Symbol
PGEN on Nasdaq
Industry
Pharmaceutical Preparations
Location
20374 Seneca Meadows Parkway, Germantown, Maryland
State of incorporation
Virginia
Fiscal year end
December 31
Former names
INTREXON CORP (to 1/22/2020)
Latest financial report
Q1 2024 - May 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 275 % +22.5%
Debt-to-equity 29.2 % -71.9%
Return On Assets -56.7 % -692%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 252 M shares -1.2%
Common Stock, Shares, Outstanding 250 M shares -2.05%
Entity Public Float 177 M USD +9.38%
Weighted Average Number of Shares Outstanding, Basic 249 M shares +8.47%
Weighted Average Number of Shares Outstanding, Diluted 249 M shares +8.47%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 22.1 M USD -39.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -97.3 M USD -23.5%
Income Tax Expense (Benefit) -432 K USD -132%
Net Income (Loss) Attributable to Parent -96.9 M USD -490%
Earnings Per Share, Basic -0.39 USD/shares -379%
Earnings Per Share, Diluted -0.39 USD/shares -379%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 17.5 M USD +79.4%
Cash, Cash Equivalents, and Short-term Investments 44.8 M USD
Accounts Receivable, after Allowance for Credit Loss, Current 872 K USD -50.8%
Assets, Current 49.5 M USD -64%
Property, Plant and Equipment, Net 12.6 M USD +82.7%
Operating Lease, Right-of-Use Asset 6.66 M USD -12.6%
Intangible Assets, Net (Excluding Goodwill) 38.7 M USD -11.7%
Goodwill 26.6 M USD -28.2%
Other Assets, Noncurrent 751 K USD -25.2%
Assets 135 M USD -44.2%
Accounts Payable, Current 4.72 M USD +23.8%
Employee-related Liabilities, Current 9.96 M USD +101%
Contract with Customer, Liability, Current 407 K USD +2613%
Liabilities, Current 28.8 M USD -38.4%
Contract with Customer, Liability, Noncurrent 1.89 M USD +3.85%
Deferred Income Tax Liabilities, Net 1.78 M USD -20.5%
Operating Lease, Liability, Noncurrent 5.39 M USD -18.7%
Other Liabilities, Noncurrent 50 K USD -50%
Liabilities 37.8 M USD -34.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.8 M USD -3.63%
Retained Earnings (Accumulated Deficit) -1.99 B USD -5.12%
Stockholders' Equity Attributable to Parent 97 M USD -47.3%
Liabilities and Equity 135 M USD -44.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14.1 M USD +23.4%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 24 M USD
Common Stock, Shares Authorized 400 M shares 0%
Common Stock, Shares, Issued 256 M shares +0.36%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9.9 M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 17.7 M USD -25.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 924 K USD -73.9%
Deferred Tax Assets, Valuation Allowance 424 M USD +5.82%
Deferred Tax Assets, Gross 434 M USD +5.67%
Operating Lease, Liability 6.71 M USD -14.8%
Depreciation 1.69 M USD -24.6%
Payments to Acquire Property, Plant, and Equipment 4.35 M USD +2725%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -97 M USD -507%
Lessee, Operating Lease, Liability, to be Paid 9.13 M USD -17.5%
Property, Plant and Equipment, Gross 37.2 M USD +20.4%
Operating Lease, Liability, Current 1.32 M USD +5.95%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.5 M USD -17.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.65 M USD -10.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Deferred Income Tax Expense (Benefit) -29 K USD +47.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.43 M USD -24.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.31 M USD -11.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.26 M USD +2.61%
Operating Lease, Payments 572 K USD +23.5%
Additional Paid in Capital 2.09 B USD +0.48%
Amortization of Intangible Assets 4.86 M USD +2.53%
Depreciation, Depletion and Amortization 1.6 M USD -6.78%
Deferred Tax Assets, Net of Valuation Allowance 9.1 M USD -0.8%
Share-based Payment Arrangement, Expense 9.34 M USD -4.47%